Pathophysiogenesis of mesial temporal lobe epilepsy: Is prevention of damage antiepileptogenic?

Current Medicinal Chemistry

Volumn 21, Issue 6, 2014, Pages 663-688

  Curia, G ^a   Lucchi, C ^a   Vinet, J ^a   Gualtieri, F ^a   Marinelli, C ^a   Torsello, A ^b   Costantino, L ^a   Biagini, G ^a,c  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c NOCSAE Baggiovara Hospital   (Italy)

Author keywords

Antiepileptic drug; Astrocyte; Blood brain barrier; Ghrelin; Growth hormone secretagogue; Hippocampus; Mesial temporal lobe epilepsy; Microglia; Neuroinflammation; Piriform cortex

Indexed keywords

ANTICONVULSIVE AGENT; ANTIINFLAMMATORY AGENT; GHRELIN; GHRELIN RECEPTOR AGONIST; GROWTH HORMONE SECRETAGOGUE; HORMONE RECEPTOR STIMULATING AGENT; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; UNCLASSIFIED DRUG;

ANTICONVULSANT THERAPY; ARTICLE; ASTROCYTE; AUTOIMMUNITY; BLOOD BRAIN BARRIER; BRAIN REGION; CELL LOSS; DRUG EFFICACY; ENCEPHALITIS; EPILEPTOGENESIS; EXPERIMENTAL THERAPY; GRANULE CELL; HIPPOCAMPUS; HUMAN; INTERNEURON; MESIAL TEMPORAL LOBE EPILEPSY; MICROGLIA; MOSSY FIBER; NERVE CELL PLASTICITY; NERVE SPROUTING; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PROPHYLAXIS; PYRIFORM CORTEX;

ANIMALS; BRAIN INJURIES; EPILEPSY, TEMPORAL LOBE; HIPPOCAMPUS; HUMANS; SCLEROSIS;

EID: 84893214866     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867320666131119152201     Document Type: Article

References (351)

1. Strzelczyk, A.; Reese, J.P.; Dodel, R.; Hamer, H.M. Cost of epilepsy: a systematic review. Pharmacoeconomics, 2008, 26, 463-476.
2. Téllez-Zenteno, J.F.; Hernández-Ronquillo, L. A review of the epidemiology of temporal lobe epilepsy. Epilepsy Res. Treat., 2012, 2012, 630853.
3. Mathern, G.W.; Pretorius, J.K.; Kornblum, H.I.; Mendoza, D.; Lozada, A.; Leite, J.P.; Chimelli, L.M.; Fried, I.; Sakamoto, A.C.; Assirati, J.A.; Lévesque, M.F.; Adelson, P.D.; Peacock, W.J. AMPA and NMDA mRNA levels in temporal lobe epilepsy patients. Brain, 1997, 120, 1937-1959.
4. Mathern, G.W.; Adelson, P.D.; Cahan, L.D.; Leite, J.P. Hippocampal neuron damage in human epilepsy: Meyer's hypothesis revisited. Prog. Brain Res., 2002, 135, 237-251.
5. Bruton, C.J. The Neuropathology of Temporal Lobe Epilepsy; Oxford: New York, 1988.
6. Mathern, G.W.; Babb, T.L.; Vickrey, B.G.; Melendez, M.; Pretorius, J.K. The clinical-pathogenic mechanisms of hippocampal neuron loss and surgical outcomes in temporal lobe epilepsy. Brain, 1995, 118, 105-118.
7. Margerison, J.H.; Corsellis, J.A. Epilepsy and the temporal lobes. A clinical, electroencephalographic and neuropathological study of the brain in epilepsy, with particular reference to the temporal lobes. Brain, 1966, 89, 499-530.
8. Mathern, G.W.; Babb, T.L.; Armstrong, D.L. Hippocampal sclerosis. In: Epilepsy: A Comprehensive Textbook; Engel, J.; Pedley, T.A., Eds.; Lippincott-Raven: Philadelphia, 1997; Vol. 1, pp. 133-155.
9. Wieser, H.G.; ILAE Commission on Neurosurgery of Epilepsy. ILAE Commission Report. Mesial temporal lobe epilepsy with hippocampal sclerosis. Epilepsia, 2004, 45, 695-714.
10. Yilmazer-Hanke, D.M.; Wolf, H.K.; Schramm, J.; Elger, C.E.; Wiestler, O.D.; Blümcke, I. Subregional pathology of the amygdala complex and entorhinal region in surgical specimens from patients with pharmacoresistant temporal lobe epilepsy. J. Neuropathol. Exp. Neurol., 2000, 59, 907-920.
11. DeCarli, C.; Hatta, J.; Fazilat, S.; Fazilat, S.; Gaillard, W.D.; Theodore, W.H. Extratemporal atrophy in patients with complex partial seizures of left temporal origin. Ann. Neurol., 1998, 43, 41-45.
12. Dreifuss, S.; Vingerhoets, F.J.; Lazeyras, F.; Andino, S.G.; Spinelli, L.; Delavelle, J.; Seeck, M. Volumetric measurements of subcortical nuclei in patients with temporal lobe epilepsy. Neurology, 2001, 57, 1636-1641.
13. Bernasconi, N.; Bernasconi, A.; Caramanos, Z.; Antel, S.B.; Andermann, F.; Arnold, D.L. Mesial temporal damage in temporal lobe epilepsy: a volumetric MRI study of the hippocampus, amygdala and parahippocampal region. Brain, 2003, 126, 462-469.
14. Keller, S.S.; Schoene-Bake, J.C.; Gerdes, J.S.; Weber, B.; Deppe, M. Concomitant fractional anisotropy and volumetric abnormalities in temporal lobe epilepsy: cross-sectional evidence for progressive neurologic injury. Plos One, 2012, 7, e46791.
15. Arellano, J.I.; Muñoz, A.; Ballesteros-Yáñez, I.; Sola, R.G.; DeFelipe, J. Histopathology and reorganization of chandelier cells in the human epileptic sclerotic hippocampus. Brain, 2004, 127, 45-64.
16. Rigau, V.; Morin, M.; Rousset, M.C.; de Bock, F.; Lebrun, A.; Coubes, P.; Picot, M.C.; Baldy-Moulinier, M.; Bockaert, J.; Crespel, A.; Lerner-Natoli, M. Angiogenesis is associated with bloodbrain barrier permeability in temporal lobe epilepsy. Brain, 2007, 130, 1942-1956.
17. Maroso, M.; Balosso, S.; Ravizza, T.; Liu, J.; Aronica, E.; Iyer, A.M.; Rossetti, C.; Molteni, M.; Casalgrandi, M.; Manfredi, A.A.; Bianchi, M.E.; Vezzani, A. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat. Med., 2010, 16, 413-419.
18. De Lanerolle, N.C.; Lee, T.S.; Spencer, D.D. In: Jasper's Basic Mechanisms of the Epilepsies, 4th ed.; Noebels, J.L.; Avoli, M.; Rogawski, M.A.; Olsen, R.W.; Delgado-Escueta, A.V., Eds.; Oxford: New York, 2012; pp. 387-404.
19. Gualtieri, F.; Marinelli, C.; Longo, D.; Pugnaghi, M.; Nichelli, P.F.; Meletti, S.; Biagini, G. Hypoxia markers are expressed in interneurons exposed to recurrent seizures. Neuromolecular Med., 2013, 15, 133-146.
20. Ben-Ari, Y.; Cossart, R. Kainate, a double agent that generates seizures: two decades of progress. Trends Neurosci., 2000, 23, 580-587.
21. Morimoto, K.; Fahnestock, M.; Racine, R.J. Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog. Neurobiol., 2004, 73, 1-60.
22. Sloviter, R.S. Hippocampal epileptogenesis in animal models of mesial temporal lobe epilepsy with hippocampal sclerosis: the importance of the "latent period" and other concepts. Epilepsia, 2008, 49, 85-92.
23. Tang, F.R.; Loke, W.K.; Ling, E.A. Comparison of status epilepticus models induced by pilocarpine and nerve agents - a systematic review of the underlying aetiology and adopted therapeutic approaches. Curr. Med. Chem., 2011, 18, 888-899.
24. Vezzani, A.; French, J.; Bartfai, T.; Baram, T.Z. The role of inflammation in epilepsy. Nat. Rev. Neurol., 2011, 7, 31-40.
25. Marchi, N.; Lerner-Natoli, M. Cerebrovascular remodeling and epilepsy. Neuroscientist, 2013, 19, 304-312.
26. Curia, G.; Longo, D.; Biagini, G.; Jones, R.S.; Avoli, M. The pilocarpine model of temporal lobe epilepsy. J. Neurosci. Methods, 2008, 172, 143-157.
27. Dalby, N.O.; Mody, I. The process of epileptogenesis: a pathophysiological approach. Curr. Opin. Neurol., 2001, 14, 187-192.
28. Löscher, W.; Brandt, C. Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research. Pharmacol. Rev., 2010, 62, 668-700.
29. Pitkänen, A.; Lukasiuk, K. Mechanisms of epileptogenesis and potential treatment targets. Lancet Neurol., 2011, 10, 173-186.
30. Avoli, M.; D'Antuono, M.; Louvel, J.; Köhling, R.; Biagini, G.; Pumain, R.; D'Arcangelo, G.; Tancredi, V. Network and pharmacological mechanisms leading to epileptiform synchronization in the limbic system in vitro. Prog. Neurobiol., 2002, 68, 167-207.
31. Lee, J.W.; Andermann, F.; Dubeau, F.; Bernasconi, A.; Mac-Donald, D.; Evans, A.; Reutens, D.C. Morphometric analysis of the temporal lobe in temporal lobe epilepsy. Epilepsia, 1998, 39, 727-736.
32. Sandok, E.K.; O'Brien, T.J.; Jack, C.R.; So, E.L. Significance of cerebellar atrophy in intractable temporal lobe epilepsy: a quantitative MRI study. Epilepsia, 2000, 41, 1315-1320.
33. Moran, N.F.; Lemieux, L.; Kitchen, N.D.; Fish, D.R.; Shorvon, S.D. Extrahippocampal temporal lobe atrophy in temporal lobe epilepsy and mesial temporal sclerosis. Brain, 2001, 124, 167-175.
34. Natsume, J.; Bernasconi, N.; Andermann, F.; Bernasconi, A. MRI volumetry of the thalamus in temporal, extratemporal, and idiopathic generalized epilepsy. Neurology, 2003, 60, 1296-1300.
35. Seidenberg, M.; Kelly, K.G.; Parrish, J.; Geary, E.; Dow, C.; Dow, C.; Rutecki, P.; Hermann, B. Ipsilateral and contralateral MRI volumetric abnormalities in chronic unilateral temporal lobe epilepsy and their clinical correlates. Epilepsia, 2005, 46, 420-430.
36. Bernasconi, N.; Bernasconi, A.; Andermann, F.; Dubeau, F.; Feindel, W.; Reutens, D.C. Entorhinal cortex in temporal lobe epilepsy: a quantitative MRI study. Neurology, 1999, 52, 1870-1876.
37. Bernasconi, N.; Bernasconi, A.; Caramanos, Z.; Andermann, F.; Dubeau, F.; Arnold, D.L. Morphometric MRI analysis of the parahippocampal region in temporal lobe epilepsy. Ann. N. Y. Acad. Sci., 2000, 911, 495-500.
38. Cendes, F.; Andermann, F.; Gloor, P.; Evans, A.; Jones-Gotman, M.; Watson, C.; Melanson, D.; Olivier, A.; Peters, T.; Lopes-Cendes, I.; Leroux, R.T. MRI volumetric measurement of amygdala and hippocampus in temporal lobe epilepsy. Neurology, 1993, 43, 719-725.
39. Jutila, L.; Ylinen, A.; Partanen, K.; Alafuzoff, I.; Mervaala, E.; Partanen, J.; Vapalahtia, M.; Vainioa, P.; Pitkänen, A. MR volumetry of the entorhinal, perirhinal, and temporopolar cortices in drugrefractory temporal lobe epilepsy. Am. J. Neuroradiol., 2001, 22, 1490-1501.
40. Salmenpera, T.; Kalviainen, R.; Partanen, K.; Mervaala, E.; Pitkänen, A. MRI volumetry of the hippocampus, amygdala, entorhinal cortex, and perirhinal cortex after status epilepticus. Epilepsy Res., 2000, 40, 155-170.
41. Du, F.; Whetsell, W.O.; Abou-Khalil, B.; Blumenkopf, B.; Lothman, E.W.; Schwarcz, R. Preferential neuronal loss in layer III of the entorhinal cortex in patients with temporal lobe epilepsy. Epilepsy Res., 1993, 16, 223-233.
42. Hudson, L.P.; Munoz, D.G.; Miller, L.; McLachlan, R.S.; Girvin, J.P.; Blume, W.T. Amygdaloid sclerosis in temporal lobe epilepsy. Ann. Neurol., 1993, 33, 622-631.
43. Miller, L.A.; McLachlan, R.S.; Bouwer, M.S.; Hudson, L.P.; Munoz, D.G. Amygdalar sclerosis: preoperative indicators and outcome after temporal lobectomy. J. Neurol. Neurosurg. Psychiatry, 1994, 57, 1099-1105.
44. Wolf, H.K.; Aliashkevich, A.F.; Blümcke, I.; Wiestler, O.D.; Zentner, J. Neuronal loss and gliosis of the amygdaloid nucleus in temporal lobe epilepsy. A quantitative analysis of 70 surgical specimens. Acta Neuropathol., 1997, 93, 606-610.
45. Aliashkevich, A.F.; Yilmazer-Hanke, D.; Van Roost, D.; Mundhenk, B.; Schramm, J.; Blümcke, I. Cellular pathology of amygdala neurons in human temporal lobe epilepsy. Acta Neuropathol., 2003, 106, 99-106.
46. Sloviter, R.S. The neurobiology of temporal lobe epilepsy: Too much information, not enough knowledge. C. R. Biol., 2005, 328, 143-153.
47. Sloviter, R.S. Experimental status epilepticus in animals: What are we modeling? Epilepsia, 2009, 50, 11-13.
48. Sperk, G. Kainic acid seizures in the rat. Prog. Neurobiol., 1994, 42, 1-32.
49. Covolan, L.; Mello, L.E. Temporal profile of neuronal injury following pilocarpine or kainic acid-induced status epilepticus. Epilepsy Res., 2000, 39, 133-152.
50. Gualtieri, F.; Curia, G.; Marinelli, C.; Biagini, G. Increased perivascular laminin predicts damage to astrocytes in CA3 and piriform cortex following chemoconvulsive treatments. Neuroscience, 2012, 218, 278-294.
51. Löscher, W.; Ebert, U. The role of the piriform cortex in kindling. Prog. Neurobiol., 1996, 50, 427-481.
52. Schwabe, K.; Ebert, U.; Löscher, W. The central piriform cortex: anatomical connections and anticonvulsant effect of GABA elevation in the kindling model. Neuroscience, 2004, 126, 727-741.
53. Kim, J.E.; Yeo, S.I.; Ryu, H.J.; Kim, M.J.; Kim, D.S.; Jo, S.M.; Kang, T.C. Astroglial loss and edema formation in the rat piriform cortex and hippocampus following pilocarpine-induced status epilepticus. J. Comp. Neurol., 2010, 518, 4612-4628.
54. Sheen, S.H.; Kim, J.E.; Ryu, H.J.; Yang, Y.; Choi, K.C.; Kang, T.C. Decrease in dystrophin expression prior to disruption of brainblood barrier within the rat piriform cortex following status epilepticus. Brain Res., 2011, 1369, 173-183.
55. Szabó, A.; Kálmán, M. Disappearance of the post-lesional laminin immunopositivity of brain vessels is parallel with the formation of gliovascular junctions and common basal lamina. A doublelabelling immunohistochemical study. Neuropathol. Appl. Neurobiol., 2004, 30, 169-177.
56. Kálmán, M.; Mahalek, J.; Adorján, A.; Adorján, I.; Pócsai, K.; Bagyura, Z.; Sadeghian, S. Alterations of the perivascular dystrophin- dystroglycan complex following brain lesions: an immunohistochemical study in rats. Histol. Histopathol., 2011, 26, 1435-1452.
57. Piredda, S.; Gale, K. A crucial epileptogenic site in the deep prepiriform cortex. Nature, 1985, 317, 623-625.
58. Löscher, W.; Ebert, U. The role of the piriform cortex in kindling. Prog. Neurobiol., 1996, 50, 427-481.
59. Laufs, H.; Richardson, M.P.; Salek-Haddadi, A.; Vollmar, C.; Duncan, J.S.; Gale, K.; Lemieux, L.; Löscher, W.; Koepp, M.J. Converging PET and fMRI evidence for a common area involved in human focal epilepsies. Neurology, 2011, 77, 904-910.
60. Tang, F.R.; Loke, W.K. Cyto-, axo- and dendro-architectonic changes of neurons in the limbic system in the mouse pilocarpine model of temporal lobe epilepsy. Epilepsy Res., 2010, 89, 43-51.
61. Dam, A.M. Epilepsy and neuron loss in the hippocampus. Epilepsia, 1980, 21, 617-629.
62. Knopp, A.; Kivi, A.; Wozny, C.; Heinemann, U.; Behr, J. Cellular and network properties of the subiculum in the pilocarpine model of temporal lobe epilepsy. J. Comp. Neurol., 2005, 483, 476-488.
63. De Guzman, P.; Inaba, Y.; Biagini, G.; Baldelli, E.; Mollinari, C.; Merlo, D.; Avoli, M. Subiculum network excitability is increased in a rodent model of temporal lobe epilepsy. Hippocampus, 2006, 16, 843-860.
64. Du, F.; Eid, T.; Lothman, E.W.; Köhler, C.; Schwarcz, R. Preferential neuronal loss in layer III of the medial entorhinal cortex in rat models of temporal lobe epilepsy. J. Neurosci., 1995, 15, 6301-6313.
65. Biagini, G.; D'Arcangelo, G.; Baldelli, E.; D'Antuono, M.; Tancredi, V.; Avoli, M. Impaired activation of CA3 pyramidal neurons in the epileptic hippocampus. Neuromolecular Med., 2005, 7, 325-342.
66. Wozny, C.; Gabriel, S.; Jandova, K.; Schulze, K.; Heinemann, U.; Behr, J. Entorhinal cortex entrains epileptiform activity in CA1 in pilocarpine-treated rats. Neurobiol. Dis., 2005, 19, 451-460.
67. Turski, W.A.; Cavalheiro, E.A.; Schwarz, M.; Czuczwar, S.L.J.; Kleinrok, Z.; Turski, L. Limbic seizures produced by pilocarpine in rats: behavioral, electroencephalographic and neuropathological study. Behav. Brain Res., 1983, 9, 315-335.
68. Pitkänen, A.; Tuunanen, J.; Kälviäinen, R.; Partanen, K.; Salmenperä, T. Amygdala damage in experimental and human temporal lobe epilepsy. Epilepsy Res., 1998, 32, 233-253.
69. Fabene, P.F.; Marzola, P.; Sbarbati, A.; Bentivoglio, M. Magnetic resonance imaging of changes elicited by status epilepticus in the rat brain: diffusion-weighted and T2-weighted images, regional blood volume maps, and direct correlation with tissue and cell damage. Neuroimage, 2003, 18, 375-389.
70. Druga, R.; Mares, P.; Otáhal, J.; Kubová, H. Degenerative neuronal changes in the rat thalamus induced by status epilepticus at different developmental stages. Epilepsy Res., 2005, 63, 43-65.
71. Biagini, G.; Baldelli, E.; Longo, D.; Contri, M.B.; Guerrini, U.; Sironi, L.; Gelosa, P.; Zini, I.; Ragsdale, D.S.; Avoli, M. Proepileptic influence of a focal vascular lesion affecting entorhinal cortex- CA3 connections after status epilepticus. J. Neuropathol. Exp. Neurol., 2008, 67, 687-701.
72. Knopp, A.; Frahm, C.; Fidzinski, P.; Witte, O.W.; Behr, J. Loss of GABAergic neurons in the subiculum and its functional implications in temporal lobe epilepsy. Brain, 2008, 131, 1516-1527.
73. He de, F.; Ma, D.L.; Tang, Y.C.; Engel, J.Jr.; Bragin, A.; Tang, F.R. Morpho-physiologic characteristics of dorsal subicular network in mice after pilocarpine-induced status epilepticus. Brain Pathol., 2010, 20, 80-95.
74. Blümcke, I.; Pauli, E.; Clusmann, H.; Schramm, J.; Becker, A.; Elger, C.; Merschhemke, M.; Meencke, H.J.; Lehmann, T.; von Deimling, A.; Scheiwe, C.; Zentner, J.; Volk, B.; Romstöck, J.; Stefan, H.; Hildebrandt, M. A new clinico-pathological classification system for mesial temporal sclerosis. Acta Neuropathol., 2007, 113, 235-244.
75. Kobayashi, M.; Wen, X.; Buckmaster, P.S. Reduced inhibition and increased output of layer II neurons in the medial entorhinal cortex in a model of temporal lobe epilepsy. J. Neurosci., 2003, 23, 8471-8479.
76. Zhang, X.; Cui, S.S.; Wallace, A.E.; Hannesson, D.K.; Schmued, L.C.; Saucier, D.M.; Honer, W.G.; Corcoran, M.E. Relations between brain pathology and temporal lobe epilepsy. J. Neurosci., 2002, 22, 6052-6061.
77. Lemos, T.; Cavalheiro, E.A. Suppression of pilocarpine-induced status epilepticus and the late development of epilepsy in rats. Exp. Brain Res., 1995, 102, 423-428.
78. Pitkänen, A.; Kharatishvili, I.; Narkilahti, S.; Lukasiuk, K.; Nissinen, J. Administration of diazepam during status epilepticus reduces development and severity of epilepsy in rat. Epilepsy Res., 2005, 63, 27-42.
79. Blümcke, I. Neuropathology of focal epilepsies: a critical review. Epilepsy Behav., 2009, 15, 34-39.
80. Sloviter, R.S.; Sollas, A.L.; Barbaro, N.M.; Laxer, K.D. Calciumbinding protein (calbindin-D28K) and parvalbumin immunocytochemistry in the normal and epileptic human hippocampus. J. Comp. Neurol., 1991, 308, 381-396.
81. Zhu, Z.Q.; Armstrong, D.L.; Hamilton, W.J.; Grossman, R.G. Disproportionate loss of CA4 parvalbumin-immunoreactive interneurons in patients with Ammon's horn sclerosis. J. Neuropathol. Exp. Neurol., 1997, 56, 988-998.
82. Maglóczky, Z.; Wittner, L.; Borhegyi, Z.; Halász, P.; Vajda, J.; Czirják, S.; Freund, T.F. Changes in the distribution and connectivity of interneurons in the epileptic human dentate gyrus. Neuroscience, 2000, 96, 7-25.
83. Andrioli, A.; Alonso-Nanclares, L.; Arellano, J.I.; DeFelipe, J. Quantitative analysis of parvalbumin-immunoreactive cells in the human epileptic hippocampus. Neuroscience, 2007, 149, 131-143.
84. Obenaus, A.; Esclapez, M.; Houser, C.R. Loss of glutamate decarboxylase mRNA-containing neurons in the rat dentate gyrus following pilocarpine-induced seizures. J. Neurosci., 1993, 13, 4470-4485.
85. Buckmaster, P.S.; Dudek, F.E. Neuron loss, granule cell axon reorganization, and functional changes in the dentate gyrus of epileptic kainate-treated rats. J. Comp. Neurol., 1997, 385, 385-404.
86. Buckmaster, P.S.; Jongen-Rêlo, A.L. Highly specific neuron loss preserves lateral inhibitory circuits in the dentate gyrus of kainateinduced epileptic rats. J. Neurosci., 1999, 19, 9519-9529.
87. André, V.; Marescaux, C.; Nehlig, A.; Fritschy, J.M. Alterations of hippocampal GABAergic system contribute to development of spontaneous recurrent seizures in the rat lithium-pilocarpine model of temporal lobe epilepsy. Hippocampus, 2001, 11, 452-468.
88. Gorter, J.A.; van Vliet, E.A.; Aronica, E.; Lopes da Silva, F.H. Progression of spontaneous seizures after status epilepticus is associated with mossy fiber sprouting and extensive bilateral loss of hilar parvalbumin and somatostatin-immunoreactive neurons. Eur. J. Neurosci., 2001, 13, 657-669.
89. Sayin, U.; Osting, S.; Hagen, J.; Rutecki, P.; Sutula, T. Spontaneous seizures and loss of axo-axonic and axo-somatic inhibition induced by repeated brief seizures in kindled rats. J. Neurosci., 2003, 23, 2759-2768.
90. Boulland, J.L.; Ferhat, L.; Tallak Solbu, T.; Ferrand, N.; Chaudhry, F.A.; Storm-Mathisen, J.; Esclapez, M. Changes in vesicular transporters for gamma-aminobutyric acid and glutamate reveal vulnerability and reorganization of hippocampal neurons following pilocarpine- induced seizures. J. Comp. Neurol., 2007, 503, 466-485.
91. Kobayashi, M.; Buckmaster, P.S. Reduced inhibition of dentate granule cells in a model of temporal lobe epilepsy. J. Neurosci., 2003, 23, 2440-2452.
92. Shao, L.R.; Dudek, F.E. Changes in mIPSCs and sIPSCs after kainate treatment: evidence for loss of inhibitory input to dentate granule cells and possible compensatory responses. J. Neurophysiol., 2005, 94, 952-960.
93. Sun, C.; Mtchedlishvili, Z.; Bertram, E.H.; Erisir, A.; Kapur, J. Selective loss of dentate hilar interneurons contributes to reduced synaptic inhibition of granule cells in an electrical stimulationbased animal model of temporal lobe epilepsy. J. Comp. Neurol., 2007, 500, 876-893.
94. Leroy, C.; Poisbeau, P.; Keller, A.F.; Nehlig, A. Pharmacological plasticity of GABAA receptors at dentate gyrus synapses in a rat model of temporal lobe epilepsy. J. Physiol., 2004, 557, 473-487.
95. Mello, L.E.; Covolan, L. Spontaneous seizures preferentially injure interneurons in the pilocarpine model of chronic spontaneous seizures. Epilepsy Res., 1996, 26, 123-129.
96. De Guzman, P.; Inaba, Y.; Baldelli, E.; de Curtis, M.; Biagini, G.; Avoli, M. Network hyperexcitability within the deep layers of the pilocarpine-treated rat entorhinal cortex. J. Physiol., 2008, 586, 1867-1883.
97. Bortel, A.; Longo, D.; de Guzman, P.; Dubeau, F.; Biagini, G.; Avoli, M. Selective changes in inhibition as determinants for limited hyperexcitability in the insular cortex of epileptic rats. Eur. J. Neurosci., 2010, 31, 2014-2023.
98. Benini, R.; Longo, D.; Biagini, G.; Avoli, M. Perirhinal cortex hyperexcitability in pilocarpine-treated epileptic rats. Hippocampus, 2011, 21, 702-713.
99. DeFelipe, J.; Garcia Sola, R.; Marco, P.; del Río, M.R.; Pulido, P.; Ramón y Cajal, S. Selective changes in the microorganization of the human epileptogenic neocortex revealed by parvalbumin immunoreactivity. Cereb. Cortex, 1993, 3, 39-48.
100. Wittner, L.; Eross, L.; Czirják, S.; Halász, P.; Freund, T.F.; Maglóczky, Z. Surviving CA1 pyramidal cells receive intact perisomatic inhibitory input in the human epileptic hippocampus. Brain, 2005, 128, 138-152.
101. Van Vliet, E.A.; Aronica, E.; Tolner, E.A.; Lopes da Silva, F.H.; Gorter, J.A. Progression of temporal lobe epilepsy in the rat is associated with immunocytochemical changes in inhibitory interneurons in specific regions of the hippocampal formation. Exp. Neurol., 2004, 187, 367-379.
102. Arteel, G.E.; Thurman, R.G.; Yates, J.M.; Raleigh, J.A. Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver. Br. J. Cancer, 1995, 72, 889-895.
103. Arteel, G.E.; Thurman, R.G.; Raleigh, J.A. Reductive metabolism of the hypoxia marker pimonidazole is regulated by oxygen tension independent of the pyridine nucleotide redox state. Eur. J. Biochem., 1998, 253, 743-750.
104. Bernhardt, B.C.; Worsley, K.J.; Kim, H.; Evans, A.C.; Bernasconi, A.; Bernasconi, N. Longitudinal and cross-sectional analysis of atrophy in pharmacoresistant temporal lobe epilepsy. Neurology, 2009, 72, 1747-1754.
105. Coan, A.C.; Appenzeller, S.; Bonilha, L.; Li, L.M.; Cendes, F. Seizure frequency and lateralization affect progression of atrophy in temporal lobe epilepsy. Neurology, 2009, 73, 834-842.
106. Sutula, T.; He, X.X.; Cavazos, J.; Scott, G. Synaptic reorganization in the hippocampus induced by abnormal functional activity. Science, 1988, 239, 1147-1150.
107. Sutula, T.; Cascino, G.; Cavazos, J.; Parada, I.; Ramirez, L. Mossy fiber synaptic reorganization in the epileptic human temporal lobe. Ann. Neurol., 1989, 26, 321-330.
108. Houser, C.R.; Miyashiro, J.E.; Swartz, B.E.; Walsh, G.O.; Rich, J.R.; Delgado-Escueta, A.V. Altered patterns of dynorphin im munoreactivity suggest mossy fiber reorganization in human hippocampal epilepsy. J. Neurosci., 1990, 10, 267-282.
109. Proper, E.A.; Oestreicher, A.B.; Jansen, G.H.; Veelen, C.W.; van Rijen, P.C.; Gispen, W.H.; de Graan, P.N. Immunohistochemical characterization of mossy fibre sprouting in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy. Brain, 2000, 123, 19-30.
110. Nadler, J.V.; Perry, B.W.; Cotman, C.W. Selective reinnervation of hippocampal area CA1 and the fascia dentata after destruction of CA3-CA4 afferents with kainic acid. Brain Res., 1980, 182, 1-9.
111. Galvis-Alonso, O.Y.; Cortes De Oliveira, J.A.; Garcia-Cairasco, N. Limbic epileptogenicity, cell loss and axonal reorganization induced by audiogenic and amygdala kindling in wistar audiogenic rats (WAR strain). Neuroscience, 2004, 125, 787-802.
112. Okazaki, M.M.; Evenson, D.A.; Nadler, J.V. Hippocampal mossy fiber sprouting and synapse formation after status epilepticus in rats: visualization after retrograde transport of biocytin. J. Comp. Neurol., 1995, 352, 515-534.
113. Spigelman, I.; Yan, X.X.; Obenaus, A.; Lee, E.Y.; Wasterlain, C.G.; Ribak, C.E. Dentate granule cells form novel basal dendrites in a rat model of temporal lobe epilepsy. Neuroscience, 1998, 86, 109-120.
114. Pierce, J.P.; Milner, T.A. Parallel increases in the synaptic and surface areas of mossy fiber terminals following seizure induction. Synapse, 2001, 39, 249-256.
115. Sloviter, R.S.; Zappone, C.A.; Harvey, B.D.; Frotscher, M. Kainic acid-induced recurrent mossy fiber innervation of dentate gyrus inhibitory interneurons: possible anatomical substrate of granule cell hyper-inhibition in chronically epileptic rats. J. Comp. Neurol., 2006, 494, 944-960.
116. Scharfman, H.E.; Goodman, J.H.; Sollas, A.L. Granule-like neurons at the hilar/CA3 border after status epilepticus and their synchrony with area CA3 pyramidal cells: functional implications of seizure-induced neurogenesis. J. Neurosci., 2000, 20, 6144-6158.
117. Lehmann, T.N.; Gabriel, S.; Eilers, A.; Njunting, M.; Kovacs, R.; Schulze, K.; Lanksch, W.R.; Heinemann, U. Fluorescent tracer in pilocarpine-treated rats shows widespread aberrant hippocampal neuronal connectivity. Eur. J. Neurosci., 2001, 14, 83-95.
118. Tang, F.R.; Chia, S.C.; Zhang, S.; Chen, P.M.; Gao, H.; Liu, C.P.; Khanna, S.; Lee, W.L. Glutamate receptor 1-immunopositive neurons in the gliotic CA1 area of the mouse hippocampus after pilocarpine- induced status epilepticus. Eur. J. Neurosci., 2005, 21, 2361-2374.
119. Zhang, S.; Khanna, S.; Tang, F.R. Patterns of hippocampal neuronal loss and axon reorganization of the dentate gyrus in the mouse pilocarpine model of temporal lobe epilepsy. J. Neurosci. Res., 2009, 87, 1135-1149.
120. Perez, Y.; Morin, F.; Beaulieu, C.; Lacaille, J.C. Axonal sprouting of CA1 pyramidal cells in hyperexcitable hippocampal slices of kainate- treated rats. Eur. J. Neurosci., 1996, 8, 736-748.
121. Cavazos, J.E.; Jones, S.M.; Cross, D.J. Sprouting and synaptic reorganization in the subiculum and CA1 region of the hippocampus in acute and chronic models of partial-onset epilepsy. Neuroscience, 2004, 126, 677-688.
122. Siddiqui, A.H.; Joseph, S.A. CA3 axonal sprouting in kainateinduced chronic epilepsy. Brain Res., 2005, 1066, 129-146.
123. Longo, B.M.; Mello, L.E. Blockade of pilocarpine- or kainateinduced mossy fiber sprouting by cycloheximide does not prevent subsequent epileptogenesis in rats. Neurosci. Lett., 1997, 226, 163-166.
124. Covolan, L.; Ribeiro, L.T.; Longo, B.M.; Mello, L.E. Cell damage and neurogenesis in the dentate granule cell layer of adult rats after pilocarpine- or kainate-induced status epilepticus. Hippocampus, 2000, 10, 169-180.
125. Williams, P.A.; Wuarin, J.P.; Doum, P.; Ferraro, D.J.; Dudek, F.E. Reassessment of the effects of cycloheximide on mossy fiber sprouting and epileptogenesis in the pilocarpine model of temporal lobe epilepsy. J. Neurophysiol., 2002, 88, 2075-2087.
126. Buckmaster, P.S.; Lew, F.H. Rapamycin suppresses mossy fiber sprouting but not seizure frequency in a mouse model of temporal lobe epilepsy. J. Neurosci., 2011, 31, 2337-2347.
127. Temple, S.; Alvarez-Buylla, A. Stem cells in the adult mammalian central nervous system. Curr. Opin. Neurobiol., 1999, 9, 135-141.
128. Scharfman, H.E.; Gray, W.P. Relevance of seizure-induced neurogenesis in animal models of epilepsy to the etiology of temporal lobe epilepsy. Epilepsia, 2007, 48, 33-41.
129. Andres-Mach, M.; Fike, J.R.; Łuszczki, J.J. Neurogenesis in the epileptic brain: a brief overview from temporal lobe epilepsy. Pharmacol. Rep., 2011, 63, 1316-1323.
130. Luskin, M.B. Restricted proliferation and migration of postnatally generated neurons derived from the forebrain subventricular zone. Neuron, 1993, 11, 173-189.
131. Eriksson, P.S.; Perfilieva, E.; Björk-Eriksson, T.; Alborn, A.M.; Nordborg, C.; Peterson, D.A.; Gage, F.H. Neurogenesis in the adult human hippocampus. Nat. Med., 1998, 4, 1313-1317.
132. Parent, J.M.; Vexler, Z.S.; Gong, C.; Derugin, N.; Ferriero, D.M. Rat forebrain neurogenesis and striatal neuron replacement after focal stroke. Ann. Neurol., 2002, 52, 802-813.
133. Dayer, A.G.; Cleaver, K.M.; Abouantoun, T.; Cameron, H.A. New GABAergic interneurons in the adult neocortex and striatum are generated from different precursors. J. Cell. Biol., 2005, 168, 415-427.
134. Hastings, N.B.; Gould, E. Rapid extension of axons into the CA3 region by adult-generated granule cells. J. Comp. Neurol., 1999, 413, 146-154.
135. Van Praag, H.; Schinder, A.F.; Christie, B.R.; Toni, N.; Palmer, T.D.; Gage, F.H. Functional neurogenesis in the adult hippocampus. Nature, 2002, 415, 1030-1034.
136. Ramirez-Amaya, V.; Marrone, D.F.; Gage, F.H.; Worley, P.F.; Barnes, C.A. Integration of new neurons into functional neural networks. J. Neurosci., 2006, 26, 12237-12241.
137. Blümcke, I.; Schewe, J.C.; Normann, S.; Brüstle, O.; Schramm, J.; Elger, C.E.; Wiestler, O.D. Increase of nestin-immunoreactive neural precursor cells in the dentate gyrus of pediatric patients with early-onset temporal lobe epilepsy. Hippocampus, 2001, 11, 311-321.
138. Crespel, A.; Rigau, V.; Coubes, P.; Rousset, M.C.; de Bock, F.; Okano, H.; Baldy-Moulinier, M.; Bockaert, J.; Lerner-Natoli, M. Increased number of neural progenitors in human temporal lobe epilepsy. Neurobiol. Dis., 2005, 19, 436-450.
139. Thom, M.; Martinian, L.; Williams, G.; Stoeber, K.; Sisodiya, S.M. Cell proliferation and granule cell dispersion in human hippocampal sclerosis. J. Neuropathol. Exp. Neurol., 2005, 64, 194-201.
140. Bengzon, J.; Kokaia, Z.; Elmér, E.; Nanobashvili, A.; Kokaia, M.; Lindvall, O. Apoptosis and proliferation of dentate gyrus neurons after single and intermittent limbic seizures. Proc. Natl. Acad. Sci. U. S. A., 1997, 94, 10432-10437.
141. Parent, J.M.; Janumpalli, S.; McNamara, J.O.; Lowenstein, D.H. Increased dentate granule cell neurogenesis following amygdala kindling in the adult rat. Neurosci. Lett., 1998, 247, 9-12.
142. Scott, B.W.; Wang, S.; Burnham, W.M.; De Boni, U.; Wojtowicz, J.M. Kindling-induced neurogenesis in the dentate gyrus of the rat. Neurosci. Lett., 1998, 248, 73-76.
143. Madsen, T.M.; Treschow, A.; Bengzon, J.; Bolwig, T.G.; Lindvall, O.; Tingström, A. Increased neurogenesis in a model of electroconvulsive therapy. Biol. Psychiatry., 2000, 47, 1043-1049.
144. Scott, B.W.; Wojtowicz, J.M.; Burnham, W.M. Neurogenesis in the dentate gyrus of the rat following electroconvulsive shock seizures. Exp. Neurol., 2000, 165, 231-236.
145. Parent, J.M.; Yu, T.W.; Leibowitz, R.T.; Geschwind, D.H.; Sloviter, R.S.; Lowenstein, D.H. Dentate granule cell neurogenesis is increased by seizures and contributes to aberrant network reorganization in the adult rat hippocampus. J. Neurosci., 1997, 17, 3727-3738.
146. Gray, W.P.; Sundstrom, L.E. Kainic acid increases the proliferation of granule cell progenitors in the dentate gyrus of the adult rat. Brain Res., 1998, 790, 52-59.
147. Kralic, J.E.; Ledergerber, D.A.; Fritschy, J.M. Disruption of the neurogenic potential of the dentate gyrus in a mouse model of temporal lobe epilepsy with focal seizures. Eur. J. Neurosci., 2005, 22, 1916-1927.
148. Mathern, G.W.; Leiphart, J.L.; De Vera, A.; Adelson, P.D.; Seki, T.; Neder, L.; Leite, J.P. Seizures decrease postnatal neurogenesis and granule cell development in the human fascia dentata. Epilepsia, 2002, 43, 68-73.
149. Pirttilä, T.J.; Lukasiuk, K.; Håkansson, K.; Grubb, A.; Abrahamson, M.; Pitkänen, A. Cystatin C modulates neurodegeneration and neurogenesis following status epilepticus in mouse. Neurobiol. Dis., 2005, 20, 241-253.
150. Pirttilä, T.J.; Manninen, A.; Jutila, L.; Nissinen, J.; Kälviäinen, R.; Vapalahti, M.; Immonen, A.; Paljärvi, L.; Karkola, K.; Alafuzoff, I.; Mervaala, E.; Pitkänen, A. Cystatin C expression is associated with granule cell dispersion in epilepsy. Ann. Neurol., 2005, 58, 211-223.
151. Devinsky, O. Diagnosis and treatment of temporal lobe epilepsy. Rev. Neurol. Dis., 2004, 1, 2-9.
152. Helmstaedter, C. Effects of chronic epilepsy on declarative memory systems. Prog. Brain Res., 2002, 135, 439-453.
153. Mazza, M.; Orsucci, F.; De Risio, S.; Bria, P.; Mazza, S. Epilepsy and depression: risk factors for suicide? Clin. Ter., 2004, 155, 425-427.
154. Detour, J.; Schroeder, H.; Desor, D.; Nehlig, A. A 5-month period of epilepsy impairs spatial memory, decreases anxiety, but spares object recognition in the lithium-pilocarpine model in adult rats. Epilepsia, 2005, 46, 499-508.
155. Amaral, D.G.; Scharfman, H.E.; Lavenex, P. The dentate gyrus: fundamental neuroanatomical organization (dentate gyrus for dummies). Prog. Brain Res., 2007, 163, 3-22.
156. Hattiangady, B.; Shetty, A.K. Decreased neuronal differentiation of newly generated cells underlies reduced hippocampal neurogenesis in chronic temporal lobe epilepsy. Hippocampus, 2010, 20, 97-112.
157. Hattiangady, B.; Rao, M.S.; Shetty, A.K. Chronic temporal lobe epilepsy is associated with severely declined dentate neurogenesis in the adult hippocampus. Neurobiol. Dis., 2004, 17, 473-490.
158. Hattiangady, B.; Shetty, A.K. Implications of decreased hippocampal neurogenesis in chronic temporal lobe epilepsy. Epilepsia, 2008, 49, 26-41.
159. Li, G.; Pleasure, S.J. Genetic regulation of dentate gyrus morphogenesis.
160. McCloskey, D.P.; Hintz, T.M.; Pierce, J.P.; Scharfman, H.E. Stereological methods reveal the robust size and stability of ectopic hilar granule cells after pilocarpine-induced status epilepticus in the adult rat. Eur. J. Neurosci., 2006, 24, 2203-2210.
161. Jessberger, S.; Zhao, C.; Toni, N.; Clemenson, G.D.; Li, Y.; Gage, F.H. Seizure-associated, aberrant neurogenesis in adult rats characterized with retrovirus-mediated cell labeling. J. Neurosci., 2007, 27, 9400-9407.
162. Pierce, J.P.; Melton, J.; Punsoni, M.; McCloskey, D.P.; Scharfman, H.E. Mossy fibers are the primary source of afferent input to ectopic granule cells that are born after pilocarpine-induced seizures. Exp. Neurol., 2005, 196, 316-331.
163. Parent, J.M.; Elliott, R.C.; Pleasure, S.J.; Barbaro, N.M.; Lowenstein, D.H. Aberrant seizure-induced neurogenesis in experimental temporal lobe epilepsy. Ann. Neurol., 2006, 59, 81-91.
164. Lurton, D.; El Bahh, B.; Sundstrom, L.; Rougier, A. Granule cell dispersion is correlated with early epileptic events in human temporal lobe epilepsy. J. Neurol. Sci., 1998, 154, 133-136.
165. Heinrich, C.; Nitta, N.; Flubacher, A.; Müller, M.; Fahrner, A.; Kirsch, M.; Freiman, T.; Suzuki, F.; Depaulis, A.; Frotscher, M.; Haas, C.A. Reelin deficiency and displacement of mature neurons, but not neurogenesis, underlie the formation of granule cell dispersion in the epileptic hippocampus. J. Neurosci., 2006, 26, 4701-4713.
166. Ma, D.L.; Tang, Y.C.; Tang, F.R. Cytoarchitectonics and afferent/ efferent reorganization of neurons in layers II and III of the lateral entorhinal cortex in the mouse pilocarpine model of temporal lobe epilepsy. J. Neurosci. Res., 2008, 86, 1324-1342.
167. Esclapez, M.; Hirsch, J.C.; Ben-Ari, Y.; Bernard, C. Newly formed excitatory pathways provide a substrate for hyperexcitability in experimental temporal lobe epilepsy. J. Comp. Neurol., 1999, 408, 449-460.
168. Lehmann, T.N.; Gabriel, S.; Kovacs, R.; Eilers, A.; Kivi, A.; Schulze, K.; Lanksch, W.R.; Meencke, H.J.; Heinemann, U. Alterations of neuronal connectivity in area CA1 of hippocampal slices from temporal lobe epilepsy patients and from pilocarpine-treated epileptic rats. Epilepsia, 2000, 41, S190-194.
169. Buzsáki, G.; Ponomareff, G.L.; Bayardo, F.; Ruiz, R.; Gage, F.H. Neuronal activity in the subcortically denervated hippocampus: a chronic model for epilepsy. Neuroscience, 1989, 28, 527-538.
170. Rafiq, A.; DeLorenzo, R.J.; Coulter, D.A. Generation and propagation of epileptiform discharges in a combined entorhinal cortex/ hippocampal slice. J. Neurophysiol., 1993, 70, 1962-1974.
171. Bragin, A.; Csicsvári, J.; Penttonen, M.; Buzsáki, G. Epileptic afterdischarge in the hippocampal-entorhinal system: current source density and unit studies. Neuroscience, 1997, 76, 1187-1203.
172. Wittner, L.; Eross, L.; Szabó, Z.; Tóth, S.; Czirják, S.; Halász, P.; Freund, T.F.; Maglóczky, Z.S. Synaptic reorganization of calbindin- positive neurons in the human hippocampal CA1 region in temporal lobe epilepsy. Neuroscience, 2002, 115, 961-978.
173. De Lanerolle, N.C.; Kim, J.H.; Robbins, R.J.; Spencer, D.D. Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy. Brain Res., 1989, 495, 387-395.
174. Scharfman, H.E.; Sollas, A.E.; Berger, R.E.; Goodman, J.H.; Pierce, J.P. Perforant path activation of ectopic granule cells that are born after pilocarpine-induced seizures. Neuroscience, 2003, 121, 1017-1029.
175. Sadgrove, M.P.; Chad, J.E.; Gray, W.P. Kainic acid induces rapid cell death followed by transiently reduced cell proliferation in the immature granule cell layer of rat organotypic hippocampal slice cultures. Brain Res., 2005, 1035, 111-119.
176. Smith, P.D.; McLean, K.J.; Murphy, M.A.; Turnley, A.M.; Cook, M.J. Seizures, not hippocampal neuronal death, provoke neurogenesis in a mouse rapid electrical amygdala kindling model of seizures. Neuroscience, 2005, 136, 405-415.
177. Mohapel, P.; Ekdahl, C.T.; Lindvall, O. Status epilepticus severity influences the long-term outcome of neurogenesis in the adult dentate gyrus. Neurobiol. Dis., 2004, 15, 196-205.
178. Borges, K.; McDermott, D.; Irier, H.; Smith, Y.; Dingledine, R. Degeneration and proliferation of astrocytes in the mouse dentate gyrus after pilocarpine-induced status epilepticus. Exp. Neurol., 2006, 201, 416-427.
179. Kim, D.S.; Kim, J.E.; Kwak, S.E.; Choi, K.C.; Kim, D.W.; Kwon, O.S.; Choi, S.Y.; Kang, T.C. Spatiotemporal characteristics of astroglial death in the rat hippocampo-entorhinal complex following pilocarpine-induced status epilepticus. J. Comp. Neurol., 2008, 511, 581-598.
180. Yang, Y.; Ge, W.; Chen, Y.; Zhang, Z.; Shen, W.; Wu, C.; Poo, M.; Duan, S. Contribution of astrocytes to hippocampal long-term potentiation through release of D-serine. Proc. Natl. Acad. Sci. U. S. A., 2003, 100, 15194-15199.
181. Pascual, O.; Casper, K.B.; Kubera, C.; Zhang, J.; Revilla-Sanchez, R.; Sul, J.Y.; Takano, H.; Moss, S.J.; McCarthy, K.; Haydon, P.G. Astrocytic purinergic signaling coordinates synaptic networks. Science, 2005, 310, 113-116.
182. Perea, G.; Navarrete, M.; Araque, A. Tripartite synapses: astrocytes process and control synaptic information. Trends Neurosci., 2009, 32, 421-431.
183. Volterra, A.; Meldolesi, J. Astrocytes, from brain glue to communication elements: the revolution continues. Nat. Rev. Neurosci., 2005, 6, 626-640.
184. Haydon, P.G.; Carmignoto, G. Astrocyte control of synaptic transmission and neurovascular coupling. Physiol. Rev., 2006, 86, 1009-1031.
185. Santello, M.; Volterra, A. Synaptic modulation by astrocytes via Ca2+-dependent glutamate release. Neuroscience, 2009, 158, 253-259.
186. Halassa, M.M.; Haydon, P.G. Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior. Annu. Rev. Physiol., 2010, 72, 335-355.
187. Angulo, M.C.; Kozlov, A.S.; Charpak, S.; Audinat, E. Glutamate released from glial cells synchronizes neuronal activity in the hippocampus. J. Neurosci., 2004, 24, 6920-6927.
188. Fellin, T.; Pascual, O.; Gobbo, S.; Pozzan, T.; Haydon, P.G.; Carmignoto, G. Neuronal synchrony mediated by astrocytic glutamate through activation of extrasynaptic NMDA receptors. Neuron, 2004, 43, 729-743.
189. Tian, G.F.; Azmi, H.; Takano, T.; Xu, Q.; Peng, W.; Lin, J.; Oberheim, N.; Lou, N.; Wang, X.; Zielke, H.R.; Kang, J.; Nedergaard, M. An astrocytic basis of epilepsy. Nat. Med., 2005, 11, 973-981.
190. Gómez-Gonzalo, M.; Losi, G.; Chiavegato, A.; Zonta, M.; Cammarota, M.; Brondi, M.; Vetri, F.; Uva, L.; Pozzan, T.; de Curtis, M.; Ratto, G.M.; Carmignoto, G. An excitatory loop with astrocytes contributes to drive neurons to seizure threshold. Plos Biol., 2010, 8, e1000352.
191. Carmignoto, G.; Haydon, P.G. Astrocyte calcium signaling and epilepsy. Glia, 2012, 60, 1227-1233.
192. Reato, D.; Cammarota, M.; Parra, L.C.; Carmignoto, G. Computational model of neuron-astrocyte interactions during focal seizure generation. Front. Comput. Neurosci., 2012, 6, 81.
193. Coiret, G.; Ster, J.; Grewe, B.; Wendling, F.; Helmchen, F.; Gerber, U.; Benquet, P. Neuron to astrocyte communication via cannabinoid receptors is necessary for sustained epileptiform activity in rat hippocampus. Plos One, 2012, 7, e37320.
194. Eid, T.; Williamson, A.; Lee, T.S.; Petroff, O.A.; de Lanerolle, N.C. Glutamate and astrocytes-key players in human mesial temporal lobe epilepsy? Epilepsia, 2008, 49, 42-52.
195. Perez, E.L.; Lauritzen, F.; Wang, Y.; Lee, T.S.; Kang, D.; Zaveri, H.P.; Chaudhry, F.A.; Ottersen, O.P.; Bergersen, L.H.; Eid, T. Evidence for astrocytes as a potential source of the glutamate excess in temporal lobe epilepsy. Neurobiol. Dis., 2012, 47, 331-337.
196. Tanaka, K.; Watase, K.; Manabe, T.; Yamada, K.; Watanabe, M.; Takahashi, K.; Iwama, H.; Nishikawa, T.; Ichihara, N.; Kikuchi, T.; Okuyama, S.; Kawashima, N.; Hori, S.; Takimoto, M.; Wada, K. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science, 1997, 276, 1699-1702.
197. Pirttimaki, T.; Parri, H.R.; Crunelli, V. Astrocytic GABA transporter GAT-1 dysfunction in experimental absence seizures. J. Physiol., 2013, 591, 823-833.
198. Zwain, I.H.; Yen, S.S. Neurosteroidogenesis in astrocytes, oligodendrocytes, and neurons of cerebral cortex of rat brain. Endocrinology, 1999, 140, 3843-3852.
199. Sedlácek, M.; Korínek, M.; Petrovic, M.; Cais, O.; Adamusová, E.; Chodounská, H.; Vyklický, L. Neurosteroid modulation of ionotropic glutamate receptors and excitatory synaptic transmission. Physiol. Res., 2008, 57, S49-57.
200. Kussius, C.L.; Kaur, N.; Popescu, G.K. Pregnanolone sulfate promotes desensitization of activated NMDA receptors. J. Neurosci., 2009, 29, 6819-6827.
201. Zheng, P. Neuroactive steroid regulation of neurotransmitter release in the CNS: action, mechanism and possible significance. Prog. Neurobiol., 2009, 89, 134-152.
202. Mellon, S.H.; Griffin, L.D. Synthesis, regulation, and function of neurosteroids. Endocr. Res., 2002, 28, 463.
203. Rolls, A.; Shechter, R.; Schwartz, M. The bright side of the glial scar in CNS repair. Nat. Rev. Neurosci., 2009, 10, 235-241.
204. Seth, P.; Koul, N. Astrocyte, the star avatar: redefined. J. Biosci., 2008, 33, 405-421.
205. Charalampopoulos, I.; Remboutsika, E.; Margioris, A.N.; Gravanis, A. Neurosteroids as modulators of neurogenesis and neuronal survival. Trends Endocrinol. Metab., 2008, 19, 300-307.
206. Wang, J.M.; Liu, L.; Irwin, R.W.; Chen, S.; Brinton, R.D. Regenerative potential of allopregnanolone. Brain Res. Rev., 2008, 57, 398-409.
207. Ortinski, P.I.; Dong, J.; Mungenast, A.; Yue, C.; Takano, H.; Watson, D.J.; Haydon, P.G.; Coulter, D.A. Selective induction of astrocytic gliosis generates deficits in neuronal inhibition. Nat. Neurosci., 2010, 13, 584-591.
208. Oberheim, N.A.; Tian, G.F.; Han, X.; Peng, W.; Takano, T.; Ransom, B.; Nedergaard, M. Loss of astrocytic domain organization in the epileptic brain. J. Neurosci., 2008, 28, 3264-3276.
209. Li, T.; Ren, G.; Lusardi, T.; Wilz, A.; Lan, J.Q.; Iwasato, T.; Itohara, S.; Simon, R.P.; Boison, D. Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice. J. Clin. Invest., 2008, 118, 571-582.
210. Benkovic, S.A.; O'Callaghan, J.P.; Miller, D.B. Regional neuropathology following kainic acid intoxication in adult and aged C57BL/6J mice. Brain Res., 2006, 1070, 215-231.
211. Schmidt-Kastner, R.; Ingvar, M. Loss of immunoreactivity for glial fibrillary acidic protein (GFAP) in astrocytes as a marker for profound tissue damage in substantia nigra and basal cortical areas after status epilepticus induced by pilocarpine in rat. Glia, 1994, 12, 165-172.
212. Ingvar, M.; Schmidt-Kastner, R.; Meller, D. Immunohistochemical markers for neurons and astrocytes show pannecrosis following infusion of high-dose NMDA into rat cortex. Exp. Neurol., 1994, 128, 249-259.
213. Nimmerjahn, A.; Kirchhoff, F.; Helmchen, F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science, 2005, 308, 1314-1318.
214. Kettenmann, H.; Hanisch, U.K.; Noda, M.; Verkhratsky, A. Physiology of microglia. Physiol. Rev., 2011, 91, 461-553.
215. Tremblay, M.È.; Lowery, R.L.; Majewska, A.K. Microglial interactions with synapses are modulated by visual experience. Plos Biol., 2010, 8, e1000527.
216. Li, Y.; Du, X.F.; Liu, C.S.; Wen, Z.L.; Du, J.L. Reciprocal regulation between resting microglial dynamics and neuronal activity in vivo. Dev. Cell, 2012, 23, 1189-1202.
217. Moriguchi, S.; Mizoguchi, Y.; Tomimatsu, Y.; Hayashi, Y.; Kadowaki, T.; Kagamiishi, Y.; Katsube, N.; Yamamoto, K.; Inoue, K.; Watanabe, S.; Nabekura, J.; Nakanishi, H. Potentiation of NMDA receptor-mediated synaptic responses by microglia. Mol. Brain Res., 2003, 119, 160-169.
218. Hayashi, Y.; Ishibashi, H.; Hashimoto, K.; Nakanishi, H. Potentiation of the NMDA receptor-mediated responses through the activation of the glycine site by microglia secreting soluble factors. Glia, 2006, 53, 660-668.
219. Costello, D.A.; Lyons, A.; Denieffe, S.; Browne, T.C.; Cox, F.F.; Lynch, M.A. Long term potentiation is impaired in membrane glycoprotein CD200-deficient mice: a role for Toll-like receptor activation. J. Biol. Chem., 2011, 286, 34722-34732.
220. Rogers, J.T.; Morganti, J.M.; Bachstetter, A.D.; Hudson, C.E.; Peters, M.M.; Grimmig, B.A.; Weeber, E.J.; Bickford, P.C.; Gemma, C. CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity. J. Neurosci., 2011, 31, 16241-16250.
221. Meucci, O.; Fatatis, A.; Simen, A.A.; Bushell, T.J.; Gray, P.W.; Miller, R.J. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc. Natl. Acad. Sci. U. S. A., 1998, 95, 14500-14505.
222. Ragozzino, D.; Di Angelantonio, S.; Trettel, F.; Bertollini, C.; Maggi, L.; Gross, C.; Charo, I.F.; Limatola, C.; Eusebi, F. Chemokine fractalkine/CX3CL1 negatively modulates active glutamatergic synapses in rat hippocampal neurons. J. Neurosci., 2006, 26, 10488-10498.
223. Hanisch, U.K.; Kettenmann, H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci., 2007, 10, 1387-1394.
224. Coull, J.A.; Boudreau, D.; Bachand, K.; Prescott, S.A.; Nault, F.; Sík, A.; De Koninck, P.; De Koninck, Y. Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain. Nature, 2003, 424, 938-942.
225. Coull, J.A.; Beggs, S.; Boudreau, D.; Boivin, D.; Tsuda, M.; Inoue, K.; Gravel, C.; Salter, M.W.; De Koninck, Y. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature, 2005, 438, 1017-1021.
226. Nicol, G.D.; Lopshire, J.C.; Pafford, C.M. Tumor necrosis factor enhances the capsaicin sensitivity of rat sensory neurons. J. Neurosci., 1997, 17, 975-982.
227. Zhang, R.; Yamada, J.; Hayashi, Y.; Wu, Z.; Koyama, S.; Nakanishi, H. Inhibition of NMDA-induced outward currents by interleukin- 1beta in hippocampal neurons. Biochem. Biophys. Res. Commun., 2008, 372, 816-820.
228. Balosso, S.; Ravizza, T.; Pierucci, M.; Calcagno, E.; Invernizzi, R.; Di Giovanni, G.; Esposito, E.; Vezzani, A. Molecular and functional interactions between tumor necrosis factor-alpha receptors and the glutamatergic system in the mouse hippocampus: implications for seizure susceptibility. Neuroscience, 2009, 161, 293-300.
229. Rossi, S.; Furlan, R.; De Chiara, V.; Motta, C.; Studer, V.; Mori, F.; Musella, A.; Bergami, A.; Muzio, L.; Bernardi, G.; Battistini, L.; Martino, G.; Centonze, D. Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis. Ann. Neurol., 2012, 71, 76-83.
230. Lucin, K.M.; Wyss-Coray, T. Immune activation in brain aging and neurodegeneration: too much or too little? Neuron, 2009, 64, 110-122.
231. Pascual, O.; Ben Achour, S.; Rostaing, P.; Triller, A.; Bessis, A. Microglia activation triggers astrocyte-mediated modulation of excitatory neurotransmission. Proc. Natl. Acad. Sci. U. S. A., 2012, 109, E197-205.
232. Rodgers, K.M.; Hutchinson, M.R.; Northcutt, A.; Maier, S.F.; Watkins, L.R.; Barth, D.S. The cortical innate immune response increases local neuronal excitability leading to seizures. Brain, 2009, 132, 2478-2486.
233. Dereymaeker, A.; Sorel, L. Experimental epilepsy and blood-brain barrier. Epilepsia, 1967, 8, 145-156.
234. Cutler, R.W.; Lorenzo, A.V.; Barlow, C.F. Changes in blood-brain permeability during pharmacologically induced convulsions. Prog. Brain Res., 1968, 29, 367-384.
235. Bolwig, T.G.; Hertz, M.M.; Westergaard, E. Blood-brain barrier permeability to protein during epileptic seizures in the rat. Acta Neurol. Scand. Suppl., 1977, 64, 226-227.
236. Mihály, A.; Bozóky, B. Immunohistochemical localization of extravasated serum albumin in the hippocampus of human subjects with partial and generalized epilepsies and epileptiform convulsions. Acta Neuropathol., 1984, 65, 25-34.
237. Frigerio, F.; Frasca, A.; Weissberg, I.; Parrella, S.; Friedman, A.; Vezzani, A.; Noé, F.M. Long-lasting pro-ictogenic effects induced in vivo by rat brain exposure to serum albumin in the absence of concomitant pathology. Epilepsia, 2012, 53, 1887-1897.
238. Rutecki, P.A.; Lebeda, F.J.; Johnston, D. Epileptiform activity induced by changes in extracellular potassium in hippocampus. J. Neurophysiol., 1985, 54, 1363-1374.
239. Djukic, B.; Casper, K.B.; Philpot, B.D.; Chin, L.S.; McCarthy, K.D. Conditional knock-out of Kir4.1 leads to glial membrane depolarization, inhibition of potassium and glutamate uptake, and enhanced short-term synaptic potentiation. J. Neurosci., 2007, 27, 11354-11365.
240. Haj-Yasein, N.N.; Jensen, V.; Vindedal, G.F.; Gundersen, G.A.; Klungland, A.; Ottersen, O.P.; Hvalby, O.; Nagelhus, E.A. Evidence that compromised K+ spatial buffering contributes to the epileptogenic effect of mutations in the human Kir4.1 gene (KCNJ10). Glia, 2011, 59, 1635-1642.
241. Lee, D.J.; Hsu, M.S.; Seldin, M.M.; Arellano, J.L.; Binder, D.K. Decreased expression of the glial water channel aquaporin-4 in the intrahippocampal kainic acid model of epileptogenesis. Exp. Neurol., 2012, 235, 246-255.
242. Binder, D.K.; Nagelhus, E.A.; Ottersen, O.P. Aquaporin-4 and epilepsy. Glia, 2012, 60, 1203-1214.
243. Eid, T.; Lee, T.S.; Thomas, M.J.; Amiry-Moghaddam, M.; Bjørnsen, L.P.; Spencer, D.D.; Agre, P.; Ottersen, O.P.; de Lanerolle, N.C. Loss of perivascular aquaporin 4 may underlie deficient water and K+ homeostasis in the human epileptogenic hippocampus. Proc. Natl. Acad. Sci. U. S. A., 2005, 102, 1193-1198.
244. Ivens, S.; Kaufer, D.; Flores, L.P.; Bechmann, I.; Zumsteg, D.; Tomkins, O.; Seiffert, E.; Heinemann, U.; Friedman, A. TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain, 2007, 130, 535-547.
245. Marchi, N.; Angelov, L.; Masaryk, T.; Fazio, V.; Granata, T.; Hernandez, N.; Hallene, K.; Diglaw, T.; Franic, L.; Najm, I.; Janigro, D. Seizure-promoting effect of blood-brain barrier disruption. Epilepsia, 2007, 48, 732-742.
246. Van Vliet, E.A.; da Costa Araújo, S.; Redeker, S.; van Schaik, R.; Aronica, E.; Gorter, J.A. Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain, 2007, 130, 521-534.
247. Schoknecht, K.; Shalev, H. Blood-brain barrier dysfunction in brain diseases: clinical experience. Epilepsia, 2012, 53, 7-13.
248. Latour, L.L.; Kang, D.W.; Ezzeddine, M.A.; Chalela, J.A.; Warach, S. Early blood-brain barrier disruption in human focal brain ischemia. Ann. Neurol., 2004, 56, 468-477.
249. Herman, S.T. Epilepsy after brain insult: targeting epileptogenesis. Neurology, 2002, 59, S21-S26.
250. Hunt, R.F.; Boychuk, J.A.; Smith, B.N. Neural circuit mechanisms of post-traumatic epilepsy. Front. Cell. Neurosci., 2013, 7, 89.
251. Kanner, A.A.; Marchi, N.; Fazio, V.; Mayberg, M.R.; Koltz, M.T.; Siomin, V.; Stevens, G.H.; Masaryk, T.; Aumayr, B.; Vogelbaum, M.A.; Barnett, G.H.; Janigro, D. Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions. Cancer, 2003, 97, 2806-2813.
252. Steiner, J.; Bernstein, H.G.; Bielau, H.; Berndt, A.; Brisch, R.; Mawrin, C.; Keilhoff, G.; Bogerts, B. Evidence for a wide extraastrocytic distribution of S100B in human brain. BMC Neurosci., 2007, 8, 2.
253. Lu, C.; Li, J.; Sun, W.; Feng, L.; Li, L.; Liu, A.; Li, J.; Mao, W.; Wei, H.; Gao, L.; Zhang, X.; Huang, Z.; Meng, X.; Wang, Y. Elevated plasma S100B concentration is associated with mesial temporal lobe epilepsy in Han Chinese: a case-control study. Neurosci. Lett., 2010, 484, 139-142.
254. Skaper, S.D.; Giusti, P.; Facci, L. Microglia and mast cells: two tracks on the road to neuroinflammation. FASEB J., 2012, 26, 3103-3117.
255. Patterson, Z.R.; Holahan, M.R. Understanding the neuroinflammatory response following concussion to develop treatment strategies. Front. Cell. Neurosci., 2012, 6, 58.
256. Thiel, A.; Radlinska, B.A.; Paquette, C.; Sidel, M.; Soucy, J.P.; Schirrmacher, R.; Minuk, J. The temporal dynamics of poststroke neuroinflammation: a longitudinal diffusion tensor imaging-guided PET study with 11C-PK11195 in acute subcortical stroke. J. Nucl. Med., 2010, 51, 1404-1412.
257. Ramlackhansingh, A.F.; Brooks, D.J.; Greenwood, R.J.; Bose, S.K.; Turkheimer, F.E.; Kinnunen, K.M.; Gentleman, S.; Heckemann, R.A.; Gunanayagam, K.; Gelosa, G.; Sharp, D.J. Inflammation after trauma: microglial activation and traumatic brain injury. Ann. Neurol., 2011, 70, 374-383.
258. Fabene, P.F.; Laudanna, C.; Constantin, G. Leukocyte trafficking mechanisms in epilepsy. Mol. Immunol., 2013, 55, 100-104.
259. Fabene, P.F.; Bramanti, P.; Constantin, G. The emerging role for chemokines in epilepsy. J. Neuroimmunol., 2010, 224, 22-27.
260. Schroeter, M.; Jander, S.; Witte, O.W.; Stoll, G. Heterogeneity of the microglial response in photochemically induced focal ischemia of the rat cerebral cortex. Neuroscience, 1999, 89, 1367-1377.
261. Fabene, P.F.; Navarro Mora, G.; Martinello, M.; Rossi, B.; Merigo, F.; Ottoboni, L.; Bach, S.; Angiari, S.; Benati, D.; Chakir, A.; Zanetti, L.; Schio, F.; Osculati, A.; Marzola, P.; Nicolato, E.; Homeister, J.W.; Xia, L.; Lowe, J.B.; McEver, R.P.; Osculati, F.; Sbarbati, A.; Butcher, E.C.; Constantin, G. A role for leukocyteendothelial adhesion mechanisms in epilepsy. Nat. Med., 2008, 14, 1377-3183.
262. Hildebrandt, M.; Amann, K.; Schröder, R.; Pieper, T.; Kolodziejczyk, D.; Holthausen, H.; Buchfelder, M.; Stefan, H.; Blümcke, I. White matter angiopathy is common in pediatric patients with intractable focal epilepsies. Epilepsia, 2008, 49, 804-815.
263. Kim, J.V.; Kang, S.S.; Dustin, M.L.; McGavern, D.B. Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis. Nature, 2009, 457, 191-195.
264. Zattoni, M.; Mura, M.L.; Deprez, F.; Schwendener, R.A.; Engelhardt, B.; Frei, K.; Fritschy, J.M. Brain infiltration of leukocytes contributes to the pathophysiology of temporal lobe epilepsy. J. Neurosci., 2011, 31, 4037-4050.
265. Abraham, J.; Fox, P.D.; Condello, C.; Bartolini, A.; Koh, S. Minocycline attenuates microglia activation and blocks the long-term epileptogenic effects of early-life seizures. Neurobiol. Dis., 2012, 46, 425-430.
266. Marchi, N.; Johnson, A.J.; Puvenna, V.; Johnson, H.L.; Tierney, W.; Ghosh, C.; Cucullo, L.; Fabene, P.F.; Janigro, D. Modulation of peripheral cytotoxic cells and ictogenesis in a model of seizures. Epilepsia, 2011, 52, 1627-1634.
267. Vezzani, A.; Moneta, D.; Conti, M.; Richichi, C.; Ravizza, T.; De Luigi, A.; De Simoni, M.G.; Sperk, G.; Andell-Jonsson, S.; Lundkvist, J.; Iverfeldt, K.; Bartfai, T. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc. Natl. Acad. Sci. U. S. A., 2000, 97, 11534-11539.
268. Ravizza, T.; Lucas, S.M.; Balosso, S.; Bernardino, L.; Ku, G.; Noé, F.; Malva, J.; Randle, J.C.; Allan, S.; Vezzani, A. Inactivation of caspase-1 in rodent brain: a novel anticonvulsive strategy. Epilepsia, 2006, 47, 1160-1168.
269. Maroso, M.; Balosso, S.; Ravizza, T.; Iori, V.; Wright, C.I.; French, J.; Vezzani, A. Interleukin-1β biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice. Neurotherapeutics, 2011, 8, 304-315.
270. Penkowa, M.; Molinero, A.; Carrasco, J.; Hidalgo, J. Interleukin-6 deficiency reduces the brain inflammatory response and increases oxidative stress and neurodegeneration after kainic acid-induced seizures. Neuroscience, 2001, 102, 805-818.
271. Mirrione, M.M.; Konomos, D.K.; Gravanis, I.; Dewey, S.L.; Aguzzi, A.; Heppner, F.L.; Tsirka, S.E. Microglial ablation and lipopolysaccharide preconditioning affects pilocarpine-induced seizures in mice. Neurobiol. Dis., 2010, 39, 85-97.
272. Durmus, H.; Kurtuncu, M.; Tuzun, E.; Pehlivan, M.; Akman-Demir, G.; Yapici, Z.; Eraksoy, M. Comparative clinical characteristics of early- and adult-onset multiple sclerosis patients with seizures. Acta Neurol. Belg., 2013, in press. Doi: 10.1007/s13760-013-0210-x
273. Sander, J.W. The epidemiology of epilepsy revisited. Curr. Opin. Neurol., 2003, 16, 165-170.
274. Errichiello, L.; Striano, S.; Zara, F.; Striano, P. Temporal lobe epilepsy and anti glutamic acid decarboxylase autoimmunity. Neurol. Sci., 2011, 32, 547-550.
275. Giometto, B.; Nicolao, P.; Macucci, M.; Tavolato, B.; Foxon, R.; Bottazzo, G.F. Temporal-lobe epilepsy associated with glutamicacid- decarboxylase autoantibodies. Lancet, 1998, 352, 457.
276. Errichiello, L.; Perruolo, G.; Pascarella, A.; Formisano, P.; Minetti, C.; Striano, S.; Zara, F.; Striano, P. Autoantibodies to glutamic acid decarboxylase (GAD) in focal and generalized epilepsy: A study on 233 patients. J. Neuroimmunol., 2009, 211, 120-123.
277. Peltola, J.; Kulmala, P.; Isojärvi, J.; Saiz, A.; Latvala, K.; Palmio, J.; Savola, K.; Knip, M.; Keränen, T.; Graus, F. Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology, 2000, 55, 46-50.
278. D'Ambrosio, R.; Eastman, C.L.; Darvas, F.; Fender, J.S.; Verley, D.R.; Farin, F.M.; Wilkerson, H.W.; Temkin, N.R.; Miller, J.W.; Ojemann, J.; Rothman, S.M.; Smyth, M.D. Mild passive focal cooling prevents epileptic seizures after head injury in rats. Ann. Neurol., 2013, 73, 199-209.
279. Brandt, C.; Potschka, H.; Löscher, W.; Ebert, U. N-methyl-Daspartate receptor blockade after status epilepticus protects against limbic brain damage but not against epilepsy in the kainate model of temporal lobe epilepsy. Neuroscience, 2003, 118, 727-740.
280. Regesta, G.; Tanganelli, P. Clinical aspects and biological bases of drug-resistant epilepsies. Epilepsy Res., 1999, 34, 109-122.
281. Elger, C.E. Pharmacoresistance: modern concept and basic data derived from human brain tissue. Epilepsia, 2003, 44, 9-15.
282. Pitkänen, A. Efficacy of current antiepileptics to prevent neurodegeneration in epilepsy models. Epilepsy Res., 2002, 50, 141-160.
283. Biagini, G.; Avoli, M.; Marcinkiewicz, J.; Marcinkiewicz, M. Brain-derived neurotrophic factor superinduction parallels antiepileptic- neuroprotective treatment in the pilocarpine epilepsy model. J. Neurochem., 2001, 76, 1814-1822.
284. Schwartz, R.D.; Yu, X.; Katzman, M.R.; Hayden-Hixson, D.M.; Perry, J.M. Diazepam, given postischemia, protects selectively vulnerable neurons in the rat hippocampus and striatum. J. Neurosci., 1995, 15, 529-539.
285. Calabresi, P.; Cupini, L.M.; Centonze, D.; Pisani, F.; Bernardi, G. Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia. Ann. Neurol., 2003, 53, 693-702.
286. Tremont-Lukats, I.W.; Ratilal, B.O.; Armstrong, T.; Gilbert, M.R. Antiepileptic drugs for preventing seizures in people with brain tumors. Cochrane Database Syst. Rev., 2008, 2, CD004424.
287. Pulman, J.; Greenhalgh, J.; Marson, A.G. Antiepileptic drugs as prophylaxis for post-craniotomy seizures. Cochrane Database Syst. Rev., 2013, 2, CD007286.
288. Temkin, N.R. Preventing and treating posttraumatic seizures: the human experience. Epilepsia, 2009, 50, 10-13.
289. Gobbo, O.L.; O'Mara, S.M. Post-treatment, but not pre-treatment, with the selective cyclooxygenase-2 inhibitor celecoxib markedly enhances functional recovery from kainic acid-induced neurodegeneration. Neuroscience, 2004, 125, 317-327.
290. Jung, K.H.; Chu, K.; Lee, S.T.; Kim, J.; Sinn, D.I.; Kim, J.M.; Park, D.K.; Lee, J.J.; Kim, S.U.; Kim, M.; Lee, S.K.; Roh, J.K. Cyclooxygenase- 2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus. Neurobiol. Dis., 2006, 23, 237-246.
291. Polascheck, N.; Bankstahl, M.; Löscher, W. The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy. Exp. Neurol., 2010, 224, 219-233.
292. Kwon, Y.S.; Pineda, E.; Auvin, S.; Shin, D.; Mazarati, A.; Sankar, R. Neuroprotective and antiepileptogenic effects of combination of anti-inflammatory drugs in the immature brain. J. Neuroinflammation, 2013, 10, 30.
293. Inoki, K.; Corradetti, M.N.; Guan, K.L. Dysregulation of the TSCmTOR pathway in human disease. Nat. Genet., 2005, 37, 19-24.
294. Crino, P.B. mTOR: A pathogenic signaling pathway in developmental brain malformations. Trends Mol. Med., 2011, 17, 734-742.
295. Kwiatkowski, D.J. Tuberous sclerosis: from tubers to mTOR. Ann. Hum. Genet., 2003, 67, 87-96.
296. Hoeffer, C.A.; Klann, E. mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci., 2010, 33, 67-75.
297. Galanopoulou, A.S.; Buckmaster, P.S.; Staley, K.J.; Moshe, S.L.; Perucca, E.; Engel, J.Jr.; Loscher, W.; Noebels, J.L.; Pitkänen, A.; Stables, J.; White, H.S.; O'Brien, T.J.; Simonato, M. American Epilepsy Society Basic Science Committee and the International League Against Epilepsy Working Group On Recommendations For Preclinical Epilepsy Drug Discovery. Identification of new epilepsy treatments: issues in preclinical methodology. Epilepsia, 2012, 53, 571-582.
298. Zeng, L.H.; Rensing, N.R.; Wong, M. The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy. J. Neurosci., 2009, 29, 6964-6972.
299. Sha, L.Z.; Xing, X.L.; Zhang, D.; Yao, Y.; Dou, W.C.; Jin, L.R.; Wu, L.W.; Xu, Q. Mapping the spatio-temporal pattern of the mammalian target of rapamycin (mTOR) activation in temporal lobe epilepsy. Plos One, 2012, 7, e39152.
300. Van Vliet, E.A.; Forte, G.; Holtman, L.; Den Burger, J.C.; Sinjewel, A.; De Vries, H.E.; Aronica, E.; Gorter, J.A. Inhibition of mammalian target of rapamycin reduces epileptogenesis and bloodbrain barrier leakage but not microglia activation. Epilepsia, 2012, 53, 1254-1263.
301. Sliwa, A.; Plucinska, G.; Bednarczyk, J.; Lukasiuk, K. Posttreatment with rapamycin does not prevent epileptogenesis in the amygdala stimulation model of temporal lobe epilepsy. Neurosci. Lett., 2012, 509, 105-109.
302. Huang, X.; McMahon, J.; Yang, J.; Shin, D.; Huang, Y. Rapamycin down-regulates KCC2 expression and increases seizure susceptibility to convulsants in immature rats. Neuroscience, 2012, 219, 33-47.
303. Kojima, M.; Kangawa, K. Ghrelin: structure and function. Physiol. Rev., 2005, 85, 495-522.
304. Veldhuis, J.D.; Bowers, C.Y. Integrating GHS into the Ghrelin System. Int. J. Pept., 2010, 2010, doi: 10.1155/2010/879503.
305. Laviano, A.; Molfino, A.; Rianda, S.; Rossi Fanelli, F. The growth hormone secretagogue receptor (Ghs-R). Curr. Pharm. Des., 2012, 18, 4749-4754.
306. Scheepens, A.; Sirimanne, E.S.; Breier, B.H.; Clark, R.G.; Gluckman, P.D.; Williams, C.E. Growth hormone as a neuronal rescue factor during recovery from CNS injury. Neuroscience, 2001, 104, 677-687.
307. Frago, L.M.; Pañeda, C.; Dickson, S.L.; Hewson, A.K.; Argente, J.; Chowen, J.A. Growth hormone (GH) and GH-releasing peptide-6 increase brain insulin-like growth factor-I expression and activate intracellular signaling pathways involved in neuroprotection. Endocrinology, 2002, 143, 4113-4122.
308. Lee, J.; Lim, E.; Kim, Y.; Li, E.; Park, S. Ghrelin attenuates kainic acid-induced neuronal cell death in the mouse hippocampus. J. Endocrinol., 2010, 205, 263-270.
309. Miltiadous, P.; Stamatakis, A.; Stylianopoulou, F. Neuroprotective effects of IGF-I following kainic acid-induced hippocampal degeneration in the rat. Cell. Mol. Neurobiol., 2010, 30, 347-360.
310. Xu, J.; Wang, S.; Lin, Y.; Cao, L.; Wang, R.; Chi, Z. Ghrelin protects against cell death of hippocampal neurons in pilocarpineinduced seizures in rats. Neurosci. Lett., 2009, 453, 58-61.
311. Russo, V.C.; Gluckman, P.D.; Feldman, E.L.; Werther, G.A. The insulin-like growth factor system and its pleiotropic functions in brain. Endocr. Rev., 2005, 26, 916-943.
312. Åberg, N.D.; Brywe, K.G.; Isgaard, J. Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain. ScientificWorld-Journal, 2006, 6, 53-80.
313. Gahete, M.D.; Córdoba-Chacón, J.; Kineman, R.D.; Luque, R.M.; Castaño, J.P. Role of ghrelin system in neuroprotection and cognitive functions: implications in Alzheimer's disease. Peptides, 2011, 32, 2225-2228.
314. Miltiadous, P.; Stamatakis, A.; Koutsoudaki, P.N.; Tiniakos, D.G.; Stylianopoulou, F. IGF-I ameliorates hippocampal neurodegeneration and protects against cognitive deficits in an animal model of temporal lobe epilepsy. Exp. Neurol., 2011, 231, 223-235.
315. Yepes, M.; Sandkvist, M.; Wong, M.K.; Coleman, T.A.; Smith, E.; Cohan, S.L.; Lawrence, D.A. Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis. Blood, 2000, 96, 569-576.
316. Ryu, J.K.; Jantaratnotai, N.; McLarnon, J.G. Thalidomide inhibition of vascular remodeling and inflammatory reactivity in the quinolinic acid-injected rat striatum. Neuroscience, 2009, 163, 601-608.
317. Shigematsu, K.; Kamo, H.; Akiguchi, I.; Kimura, J.; Kameyama, M.; Kimura, H. Neovascularization in kainic acid-induced lesions of rat striatum. An immunohistochemical study with laminin. Brain Res., 1989, 501, 215-222.
318. Yepes, M.; Sandkvist, M.; Coleman, T.A.; Moore, E.; Wu, J.Y.; Mitola, D.; Bugge, T.H.; Lawrence, D.A. Regulation of seizure spreading by neuroserpin and tissue-type plasminogen activator is plasminogen-independent. J. Clin. Invest., 2002, 109, 1571-1578.
319. Sarkar, S.; Raymick, J.; Schmued, L. Temporal progression of kainic acid induced changes in vascular laminin expression in rat brain with neuronal and glial correlates. Curr. Neurovasc. Res., 2012, 9, 110-119.
320. Wagner, S.; Tagaya, M.; Koziol, J.A.; Quaranta, V.; Del Zoppo, G.J. Rapid disruption of an astrocyte interaction with the extracellular matrix mediated by integrin α6β4 during focal cerebral ischemia/ reperfusion. Stroke, 1997, 28, 858-865.
321. Zhang, C.; An, J.; Haile, W.B.; Echeverry, R.; Strickland, D.K.; Yepes, M. Microglial low-density lipoprotein receptor-related protein 1 mediates the effect of tissue-type plasminogen activator on matrix metalloproteinase-9 activity in the ischemic brain. J. Cereb. Blood Flow Metab., 2009, 29, 1946-1954.
322. Szabó, A.; Kálmán, M. Post traumatic lesion absence of β- dystroglycan-immunopositivity in brain vessels coincides with the glial reaction and the immunoreactivity of vascular laminin. Curr. Neurovasc. Res., 2008, 5, 206-213.
323. Jo, S.M.; Ryu, H.J.; Kim, J.E.; Yeo, S.I.; Kim, M.J.; Choi, H.C.; Song, H.K.; Kang, T.C. Up-regulation of endothelial endothelin-1 expression prior to vasogenic edema formation in the rat piriform cortex following status epilepticus. Neurosci. Lett., 2011, 501, 25-30.
324. Agnati, L.F.; Zoli, M.; Kurosawa, M.; Benfenati, F.; Biagini, G.; Zini, I.; Hallström, A.; Ungerstedt, U.; Toffano, G.; Fuxe, K. A new model of focal brain ischemia based on the intracerebral injection of endothelin-1. J. Neurol. Sci., 1991, 12, 49-53.
325. Howells, D.W.; Porritt, M.J.; Rewell, S.S.; O'Collins, V.; Sena, E.S.; Van der Worp, H.B.; Traystman, R.J.; Macleod, M.R. Different strokes for different folks: the rich diversity of animal models of focal cerebral ischemia. J. Cereb. Blood Flow Metab., 2010, 30, 1412-1431.
326. Liu, D.; Smith, C.L.; Barone, F.C.; Ellison, J.A.; Lysko, P.G.; Li, K.; Simpson, I.A. Astrocytic demise precedes delayed neuronal death in focal ischemic rat brain. Mol. Brain Res., 1999, 68, 29-41.
327. Qin, A.P.; Liu, C.F.; Qin, Y.Y.; Hong, L.Z.; Xu, M.; Yang, L.; Liu, J.; Qin, Z.H.; Zhang, H.L. Autophagy was activated in injured astrocytes and mildly decreased cell survival following glucose and oxygen deprivation and focal cerebral ischemia. Autophagy, 2010, 6, 738-753.
328. Nargund, R.P.; Patchett, A.A.; Bach, M.A.; Murphy, M.G.; Smith, R.G. Peptidomimetic growth hormone secretagogues. Design considerations and therapeutic potential. J. Med. Chem., 1998, 41, 3103-3127.
329. Guerlavais, V.; Boeglin, D.; Mousseaux, D.; Oiry, C.; Heitz, A.; Deghenghi, R.; Locatelli, V.; Torsello, A.; Ghe, C.; Catapano, F.; Muccioli, G.; Galleyrand, J.C.; Fehrentz, J.A.; Martinez, J. New active series of growth hormone secretagogues. J. Med. Chem., 2003, 46, 1191-1203.
330. Moulin, A.; Demange, L.; Berge, G.; Gagne, D.; Ryan, J.; Mousseaux, D.; Heitz, A.; Perrisoud, D.; Locatelli, V.; Torsello, A.; Galleyrand, J.C.; Fehrentz, J.A.; Martinez, J. Toward potent ghrelin receptor ligands based on trisubstituted 1,2,4-triazole structure. 2. Synthesis and pharmacological in vitro and in vivo evaluations. J. Med. Chem., 2007, 50, 5790-5806.
331. Moulin, A.; Demange, L.; Ryan, J.; Mousseaux, D.; Sanchez, P.; Berge, P.; Gagne, D.; Perrissoud, D.; Locatelli, V.; Torsello, A.; Galleyrand, J.C.; Fehrentz, J.A.; Martinez, J. New trisubstituted 1,2,4-triazole derivatives as potent ghrelin receptor antagonists. 3. Synthesis and pharmacological in vitro and in vivo evaluations. J. Med. Chem., 2008, 51, 689-693.
332. Demange, L.; Boeglin, D.; Moulin, A.; Mousseaux, D.; Ryan, J.; Berge, G.; Gagne, D.; Heitz, A.; Perrisoud, D.; Locatelli, V.; Torsello, A.; Galleyrand, J.C.; Fehrentz, J.A.; Martinez, J. Synthesis and pharmacological in vitro and in vivo evaluations of novel triazole derivatives as ligands of the ghrelin receptor 1. J. Med. Chem., 2007, 50, 1939-1957.
333. Costantino, L. Novel triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptors (WO2012035124): a patent evaluation. Exp. Opin. Ther. Patents, 2012, 22, 1099-1104.
334. Davenport, A.P.; Bonner, T.I.; Foord, S.M.; Harmar, A.J.; Neubig, R.R.; Pin, J.P.; Spedding, M.; Kojima, M.; Kangawa, K. International union of pharmacology. LVI. Ghrelin receptor nomenclature, distribution, and function. Pharmacol. Rev., 2005, 57, 541-546.
335. Costantino, L.; Barlocco, D. Ghrelin receptor modulators and their therapeutic potential. Future Med. Chem., 2009, 1, 157-177.
336. Bednarek, M.A.; Feighner, S.D.; Pong, S.S.; McKee, K.K.; Hreniuk, D.L.; Silva, M.V.; Warren, V.A.; Howard, A.D.; Van der Ploeg, L.H.Y.; Heck, J.V. Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a. J. Med. Chem., 2000, 43, 4370-4376.
337. Kojima, M.; Hosoda, H.; Date, Y.; Nakazato, M.; Matsuo, H.; Kangawa, K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature, 1999, 402, 656-660.
338. Proulx, C.; Picard, E.; Boeglin, D.; Pohankova, P.; Chemtob, S.; Ong, H.; Lubell, W.D. Azapeptide analogues of the growth hormone releasing peptide 6 as cluster of differentiation 36 receptor ligands with reduced affinity for the growth hormone secretagogue receptor 1a. J. Med. Chem., 2012, 55, 6502-6511.
339. Locatelli, V.; Rossoni, G.; Schweiger, F.; Torsello, A.; DeGennaro Colonna, V.; Bernareggi, M.; Deghenghi, R.; Muller, E.E.; Berti, F. Growth hormone-independent cardioprotective effects of hexarelin in the rat. Endocrinology, 1999, 140, 4024-4031.
340. Salome, N.; Haage, D.; Perrisoud, D.; Moulin, A.; Demange, L.; Egecioglu, E.; Fehrentz, J.A.; Martinez, J.; Dickson, S.L. Anorexigenic and electrophysiological actions of novel ghrelin receptor (GHS-R1a) antagonists in rats. Eur. J. Pharmacol., 2009, 612, 167-173.
341. Delhanty, P.J.; Neggers, S.J.; van der Lely, A.J. Des-acyl ghrelin: a metabolically active peptide. Endocr. Dev., 2013, 25, 112-121.
342. Frago, L.M.; Baquedano, E.; Argente, J.; Chowen, J.A. Neuroprotective actions of ghrelin and growth hormone secretagogues. Front. Mol. Neurosci., 2011, 4, 1-11.
343. Bayliss, J.A.; Andrews, Z.B. Ghrelin is neuroprotective in Parkinson's disease: molecular mechanisms of metabolic neuroprotection. Ther. Adv. Endocrinol. Metab., 2013, 4, 25-36.
344. Portelli, J.; Thielemans, L.; Ver Donck, L.; Loyens, E.; Coppens, J.; Aourz, N.; Aerssens, J.; Vermoesen, K.; Clinckers, R.; Schallier, A.; Michotte, Y.; Moechars, D.; Collingridge, G.L.; Bortolotto, Z.A.; Smolders, I. Inactivation of the constitutively active ghrelin receptror attenuates limbic seizure activity in rodents. Neurotherapeutics, 2012, 9, 658-672.
345. Biagini, G.; Torsello, A.; Marinelli, C.; Gualtieri, F.; Vezzali, R.; Coco, S.; Bresciani, E.; Locatelli, V. Beneficial effects of desacylghrelin, hexarelin and EP-80317 in models of status epilepticus. Eur. J. Pharmacol., 2011, 670, 130-136.
346. Freichel, C.; Potschka, H.; Ebert, U.; Brandt, C.; Löscher, W. Acute changes in the neuronal expression of GABA and glutamate decarboxylase isoforms in the rat piriform cortex following status epilepticus. Neuroscience, 2006, 141, 2177-2194.
347. Ben-Ari, Y. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience, 1985, 14, 375-403.
348. Emerson, M.R.; Nelson, S.R.; Samson, F.E.; Pazdernik, T.L. Hypoxia preconditioning attenuates brain edema associated with kainic acid-induced status epilepticus in rats. Brain Res., 1999, 825, 189-193.
349. Broglio, F.; Boutignon, F.; Benso, A.; Gottero, C.; Prodam, F.; Arvat, E.; Ghè, C.; Catapano, F.; Torsello, A.; Locatelli, V.; Muccioli, G.; Boeglin, D.; Guerlavais, V.; Fehrentz, J.A.; Martinez, J.; Ghigo, E.; Deghenghi, R. EP1572: a novel peptido-mimetic GH secretagogue with potent and selective GH-releasing activity in man. J. Endocrinol. Invest., 2002, 25, RC26-RC28.
350. Piccoli, F.; Degen, L.; MacLean, C.; Peter, S.; Baselgia, L.; Larsen, F.; Beglinger, C.; Drewe, J. Pharmacokinetics and pharmacodynamic effects of an oral ghrelin agonist in healthy subjects. J. Clin. Endocrinol. Metab., 2007, 92, 1814-1820.
351. Lucchi, C.; Curia, G.; Vinet, J.; Gualtieri, F.; Bresciani, E.; Locatelli, V.; Torsello, A.; Biagini, G. Protective but not anticonvulsant effects of ghrelin and JMV-1843 in the pilocarpine model of status epilepticus. Plos One, 2013, 8: e72716.